Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

BioPath Ventures

Status
INACTIVE
Global HQ
Millbrae, United States
Countries of investment
  • Portugal
Investment stages
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Biotechnology
  • Health Tech
  • AI
About
BioPath Ventures provides venture capital and advisory services to early-stage biotech startups with focus on novel drug modalities and platform technologies.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

BioPath Ventures targets early stage biotech and life sciences companies with high growth potential and groundbreaking technologies. The firm provides capital and strategic support to accelerate the development and commercialization of innovative health solutions.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Backed by over two decades of investment acumen, the fund manager has executed numerous successful investments across diverse sectors. With a focus on early to growth-stage companies, he has led over 50 investments primarily in North America and Europe. His strategic approach has yielded multiple high-profile exits, demonstrating a keen ability to identify and capitalize on emerging market trends. Built a robust track record in technology and healthcare, he continues to drive value through meticulous analysis and proactive portfolio management.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp